Abstract:The tumor suppressor PIP3 phosphatase PTEN is phosphorylated on four clustered Ser/Thr on its C-terminal tail (aa 380–385) and these phosphorylations are proposed to induce a reduction in PTEN’s plasma membrane recruitment. How these phosphorylations affect the structure and enzymatic function of PTEN is poorly understood. To gain insight into the mechanistic basis of PTEN regulation by phosphorylation, we generated semisynthetic site-specifically tetra-phosphorylated PTEN using expressed protein ligation. By … Show more
“…5A). To verify this, we used limited proteolysis, which is a wellcharacterized technique used to measure changes in the conformational stability and flexibility of proteins (54). Digestion of the purified ectodomain of nicastrin with varying amounts of trypsin in the presence or absence of reducing reagent revealed that reduced nicastrin was substantially more sensitive to proteolysis than the unreduced protein (Fig.…”
γ-Secretase is an intramembrane-cleaving protease that processes many type-I integral membrane proteins within the lipid bilayer, an event preceded by shedding of most of the substrate's ectodomain by α-or β-secretases. The mechanism by which γ-secretase selectively recognizes and recruits ectodomain-shed substrates for catalysis remains unclear. In contrast to previous reports that substrate is actively recruited for catalysis when its remaining short ectodomain interacts with the nicastrin component of γ-secretase, we find that substrate ectodomain is entirely dispensable for cleavage. Instead, γ-secretase-substrate binding is driven by an apparent tight-binding interaction derived from substrate transmembrane domain, a mechanism in stark contrast to rhomboid-another family of intramembrane-cleaving proteases. Disruption of the nicastrin fold allows for more efficient cleavage of substrates retaining longer ectodomains, indicating that nicastrin actively excludes larger substrates through steric hindrance, thus serving as a molecular gatekeeper for substrate binding and catalysis.
“…5A). To verify this, we used limited proteolysis, which is a wellcharacterized technique used to measure changes in the conformational stability and flexibility of proteins (54). Digestion of the purified ectodomain of nicastrin with varying amounts of trypsin in the presence or absence of reducing reagent revealed that reduced nicastrin was substantially more sensitive to proteolysis than the unreduced protein (Fig.…”
γ-Secretase is an intramembrane-cleaving protease that processes many type-I integral membrane proteins within the lipid bilayer, an event preceded by shedding of most of the substrate's ectodomain by α-or β-secretases. The mechanism by which γ-secretase selectively recognizes and recruits ectodomain-shed substrates for catalysis remains unclear. In contrast to previous reports that substrate is actively recruited for catalysis when its remaining short ectodomain interacts with the nicastrin component of γ-secretase, we find that substrate ectodomain is entirely dispensable for cleavage. Instead, γ-secretase-substrate binding is driven by an apparent tight-binding interaction derived from substrate transmembrane domain, a mechanism in stark contrast to rhomboid-another family of intramembrane-cleaving proteases. Disruption of the nicastrin fold allows for more efficient cleavage of substrates retaining longer ectodomains, indicating that nicastrin actively excludes larger substrates through steric hindrance, thus serving as a molecular gatekeeper for substrate binding and catalysis.
“…15 In addition, binding of PTEN with the plasma membrane is also regulated by the phosphorylation status of PTEN. [16][17][18] This interaction is delineated in more detail in the following sections.…”
Section: Pten and Tumor Suppressionmentioning
confidence: 99%
“…33 In addition, Tyr240 and Tyr315 phosphorylation could help to maintain phosphatase function of PTEN. 34,35 Bolduc et al 16 found that upon phosphorylation of the 380-385 Ser/Thr cluster, the PTEN C-terminal modified tail clamps down intramolecularly on the C2 domain, preventing PTEN from binding to the plasma membrane and reducing its catalytic action toward PIP3. Nguyen also proved that the phosphatase catalytic site forms the membrane-binding regulatory interface and interacts with the inhibitory phosphorylated C-terminal tail.…”
The tumor suppressor phosphatase and tensin homolog (PTEN) is a lipid and protein phosphatase that is able to antagonize the PI3K/AKT pathway and inhibit tumor growth. PTEN also possesses phosphatase-independent functions. Genetic alterations of PTEN may lead to the deregulation of cell proliferation, survival, differentiation, energy metabolism and cellular architecture and mobility. Although the role of PTEN in tumor suppression is extensively documented and well established, the evidence for its roles in immunity did not start to accumulate until recently. In this review, we will focus on the newly discovered functions of PTEN in the regulation of innate and adaptive immunity, including antiviral responses.
“…A cluster of serine and threonine residues (Ser380, Thr382, Thr383 and Ser385) in the regulatory C-terminal tail of PTEN is constitutively phosphorylated by casein kinase 2 (CK2). This results in a stable 'closed' form that has reduced lipid phosphatase activity, decreased plasma membrane targeting and increased conformational compaction [15][16][17][18][19] . Intramolecular interaction of the phosphorylated C-terminal tail with basic residues within the N-terminal PIP2-binding motif, the catalytic and C2 domains, maintains PTEN in its 'closed' form 20,21 .…”
mentioning
confidence: 99%
“…Mutation of the C-terminal tail phosphorylation cluster disrupts the intramolecular interaction and promotes an 'open' form of PTEN with increased catalytic activity and plasma membrane targeting. These findings have led to an elegant model whereby a phosphorylation-regulated switch controls the transition of PTEN from a 'closed' cytoplasmic inactive state and an 'open' active state that is localized to the plasma membrane 17,19,21 . PTEN is also phosphorylated in its C2 domain by ROCK, the downstream effector of RhoA, resulting in increased PTEN catalytic activity 22 .…”
Tumour suppressor PTEN is a phosphatase that negatively regulates the PI3K/AKT pathway. The ability to directly monitor PTEN conformation and function in a rapid, sensitive manner is a key step towards developing anti-cancer drugs aimed at enhancing or restoring PTEN-dependent pathways. Here we developed an intramolecular bioluminescence resonance energy transfer (BRET)-based biosensor, capable of detecting signal-dependent PTEN conformational changes in live cells. The biosensor retains intrinsic properties of PTEN, enabling structure-function and kinetic analyses. BRET shifts, indicating conformational change, were detected following mutations that disrupt intramolecular PTEN interactions, promoting plasma membrane targeting and also following physiological PTEN activation. Using the biosensor as a reporter, we uncovered PTEN activation by several G proteincoupled receptors, previously unknown as PTEN regulators. Trastuzumab, used to treat ERBB2-overexpressing breast cancers also elicited activation-associated PTEN conformational rearrangement. We propose the biosensor can be used to identify pathways regulating PTEN or molecules that enhance its anti-tumour activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.